Raymond James & Associates ARENA PHARMACEUTICALS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021
SELL
N/A
-4,825 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
N/A
-4,671 Reduced 49.19%
4,825 $329,000
Q1 2021

May 14, 2021
BUY
N/A
891 Added 10.35%
9,496 $659,000
Q4 2020

Feb 12, 2021
SELL
N/A
-3,448 Reduced 28.61%
8,605 $661,000
Q3 2020

Nov 04, 2020
BUY
N/A
726 Added 6.41%
12,053 $901,000
Q2 2020

Jul 28, 2020
BUY
N/A
32 Added 0.28%
11,327 $713,000
Q1 2020

Apr 21, 2020
SELL
N/A
-440 Reduced 3.75%
11,295 $474,000
Q4 2019

Feb 12, 2020
SELL
N/A
-4,048 Reduced 25.65%
11,735 $533,000
Q3 2019

Nov 07, 2019
SELL
N/A
-279 Reduced 1.74%
15,783 $722,000
Q2 2019

Aug 06, 2019
SELL
N/A
-1,371 Reduced 7.86%
16,062 $942,000
Q1 2019

May 06, 2019
BUY
N/A
17,433 New
17,433 $782,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email